Mwanzo2196 • HKG
add
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
Bei iliyotangulia
$ 12.00
Bei za siku
$ 11.82 - $ 12.32
Bei za mwaka
$ 11.32 - $ 23.20
Thamani ya kampuni katika soko
60.34B HKD
Wastani wa hisa zilizouzwa
3.84M
Uwiano wa bei na mapato
12.63
Mgao wa faida
-
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CNY) | Des 2023info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 10.70B | -13.22% |
Matumizi ya uendeshaji wa biashara | 4.97B | -6.82% |
Mapato halisi | 103.20M | -92.03% |
Kiwango cha faida halisi | 0.96 | -90.86% |
Mapato kwa kila hisa | — | — |
EBITDA | 453.50M | -61.56% |
Asilimia ya kodi ya mapato | 965.06% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CNY) | Des 2023info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 15.58B | -9.25% |
Jumla ya mali | 113.47B | 5.88% |
Jumla ya dhima | 56.85B | 7.16% |
Jumla ya hisa | 56.62B | — |
hisa zilizosalia | 2.67B | — |
Uwiano wa bei na thamani | 0.70 | — |
Faida inayotokana na mali | -0.47% | — |
Faida inayotokana mtaji | -0.58% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CNY) | Des 2023info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 103.20M | -92.03% |
Pesa kutokana na shughuli | 952.58M | -11.29% |
Pesa kutokana na uwekezaji | -535.00M | -486.22% |
Pesa kutokana na ufadhili | -939.67M | -72.55% |
Mabadiliko halisi ya pesa taslimu | -579.77M | -221.60% |
Mtiririko huru wa pesa | 2.67B | -12.67% |
Kuhusu
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1994
Tovuti
Wafanyakazi
40,370
